Physiopathological bases of the treatment of cardiac failure;Bases physiopathologiques du traitement de l'insuffisance cardiaque

Archives des Maladies du Coeur et des Vaisseaux

Volumn 91, Issue 11, 1998, Pages 1315-1324

  Vinsonneau, C ^a   Su, J B ^b   Benacerraf, S ^a   Darmon, M E ^a   Duval Moulin, A M ^a   Crozatier, B ^b   Dubois Rande J L ^a   Castaigne, A ^a   Hittinger, L ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b FACULTÉ DE MÉDECINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATINE PHOSPHATE; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NITRIC OXIDE;

ARTICLE; DISEASE PREDISPOSITION; EARLY DIAGNOSIS; ENERGY METABOLISM; HEART ARRHYTHMIA; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE CONDUCTION DISTURBANCE; HEART MUSCLE ISCHEMIA; HEART VENTRICLE REMODELING; HORMONAL REGULATION; HUMAN; PATHOPHYSIOLOGY; VASODILATATION;

CARDIOLOGY; DIAGNOSIS, DIFFERENTIAL; HEART; HEART FAILURE, CONGESTIVE; HUMANS; ISCHEMIA; MYOCARDIUM; VASODILATOR AGENTS;

EID: 0031796363     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Gheorghiade M, Bonow RO. Chronic heart failure in the United States. A manifestation of coronary artery disease. Circulation 1998 ; 97 : 282-9.
2. Starling EH. The linacre lecture on the law of the heart 1918, Londres : Longmans, Green.
3. Grossman W. Diastolic dysfunction in congestive heart failure. N Engl J Med 1991 ; 325 : 1557-64.
4. Goldsmith SR, Dick C. Differentiating systolic from diastolic heart failure: pathophysiologic and therapeutic considerations. Am J Med 1993 ; 95 : 645-55.
5. Fazio S, Sabatini D, Capaldo B et al. Preliminary study of growth hormone in the treatment of dilated cardiomyopathy. N Engl J Med 1996 ; 334 : 809-14.
6. Scorsin M, Hagege AA, Marotte F et al. Does transplantation of cardiomyocytes improve function of infarcted myocardium. Circulation 1997 ; 96 (suppl II), II-188-II193.
7. Bristow MR, Ginsburg R, Minobe W et al. Decreased catecho-lamine sensitivity ana β-adenergic-receptor density in failing human hearts. N Engl J Med 1982 ; 307 : 205-11.
8. Swynqhedauw B, Delcayre C. Biology of cardiac overload. Pathol Annu 1982 : 137-83.
9. Morgan JP, Erny RE, Allen PD et al. Abnormal intracellular calcium handling, a major cause of systolic and diastolic dysfunction in ventricular myocardium from patients with heart failure. Circulation 1990, 81 (Suppl III) : III-21-III-32.
10. Hittinger L. Physiopamologie de l'insuffisance cardiaque aiguë. In : Insuffisance cardiaque aiguë. Paris : Masson, 1996 : 3-21.
11. Cheng CP, Suzuki M, Ohte N et al. Altered ventricular ond myocyte response to angiotensin II in pacinq-induced heart failure. Circ Res 1996, 78 : 880-92.
12. Thomas PB, Liu ECK, Webb ML et al. Exogenous effects and endogenous production of endothelin in cardiac myocytes : Potential significance in heart failure. Am J Physiol 1996 ; 271 (Heart Circ Physiol 40) : H 2629-H 2637.
13. Kelly RA, Smith TW. Cytokines and cardiac contractile function. Circulation 1997 ; 95 : 778-81.
14. Levine B, Kalman J, Mayer L et al. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990 ; 223 : 236-41.
15. Kelly RA, Balligand JL, Smith TW. Nitric oxide and cardiac function. Circ Res 1996 ; 79 : 363-80.
16. Ingwall JS, Kramer MF, Fifer MA et al. The creating kinase system in normal and diseased human myocardium. N Engl J Med 1985 ; 313 : 1050-4.
17. Vainer SF, Hittinger L. Coronary vascular mechanisms involved in decompensation from hypertrophy to heart failure. J Am Coll Cardiol 1993 ; 22 (suppl A) : A 34-A 40.
18. Hittinger L, Shannon RP, Bishop SP, Gelpi RJ, Vatner SF. Subendocardial exhausion of blood flow reserve and increased fibrosis in consious dogs with heart failure. Circ Res 1989 ; 65 : 971-80.
19. Armstrong PW, Stopps TP, Fod SE et al. Rapid ventricular pacing in the dog : pathopnysiologic studies of heart failure. Circulation 1986 ; 74 : 1075-84.
20. Vasan RS, Larson MG, Benjamin EJ et al. Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction. N Engl J Med 1997 ; 336 : 1350-5.
21. CIBIS investigators and committees. A randomized trial of β-blockade in heart failure. The cardiac insufficiency bisoprofol study. Circulation 1994 ; 90 : 1765-73.
22. Packer M, Bristow MR, Cohn JN et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996 ; 334 : 1349-55.
23. The CONSENSUS trial study group. Effects of enalapril on mortality in severe heart failure. N Engl J Med 1987 ; 316 : 1429-35.
24. The SOLVD investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection and congestive heart failure. N Engl J Med 1991 ; 325 : 293-302.
25. Arnal JF, Berdeaux A, Richard V, Adnot S. Système endocrinien vasculaire, coeur et vaisseaux. In : Hormones coeur et vaisseaux. Paris : INSERM, 1997.
26. Kiowski W, Süstch G, Hunziger P et al. Evidence for endothelin-1 mediated vasoconstriction in severe chronic heart failure. Lancet 1995 ; 346 : 249-58.
27. Thibonnier M, Clauser E. Vasopressine : neurohypophyse, cœur et vaisseaux. In hormones cœur et vaisseaux. Pans : INSERM, 1997.
28. Cohn JN. Vasodilator therapy for heart failure. The influence of impedance on left ventricular performance. Circulation 1973 ; 68 : 5-8.
29. Wang J, Seyedi N, Xu Xb et al. Defective endolhelium-mediated control of coronary circulation in conscious dogs after heart failure. Am J Physiol 1994 ; 266 : H 670-H 680
30. Wang J, Geng-Hua Y, Kencht M et al. Physical training alters the pathogenesis of pacing-induced heart failure througn endothelium-mediated mechanisms in awake dogs. Circulation 1997 ; 96 : 2683-92.
31. Cohn JN, Archibald EDO, Ziesche S et al. Effect of vasodilator merapy on mortality in chronic congestive heart failure : results of the veterans administration cooperative study. N Engl J Med 1986 ; 314 : 1547-52.
32. Dussaule JC, Ledoyx S, Pham I. Systeme endocrinien cardiaque, coeur et vaisseaux. In hormones cœur et vaisseaux. Pans :INSERM, 1997.
33. Linz W, Wiemer G, Gohlke P, Unger T, Scholkens BA. Contribution or kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol Rev 1995 ; 47 : 25-49.
34. Su JB, Barbe F Houel R et al. Preserved vasodilator effect of bradykinin in dogs with heart failure. Circulation 1998 (in press).